Laimei Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Laimei Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Chongqing Laimei Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement on changes in shareholders\' shares holding 5% or more and changes in voting rights of controlling shareholders reaching 1%
Laimei Pharmaceutical: Announcement on obtaining a drug registration certificate
Laimei Pharmaceuticals: Notice on Obtaining Approval Notice for Drug Supplemental Applications
Laimei Pharmaceuticals: “Internal Audit System” (October 2024)
Laimei Pharmaceutical: Announcement of Resolutions of the 33rd Meeting of the Fifth Board of Supervisors
Lamy Pharmaceuticals: Report for the third quarter of 2024
Laimei Pharmaceutical: Announcement on deposit business and related transactions with Guangxi Beibu Gulf Bank Co., Ltd.
Laimei Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Laimei Pharmaceuticals: Announcement on preparing for asset impairment in the first three quarters of 2024
Laimei Pharmaceutical: Announcement on providing a guarantee for the financing and credit of Chongqing Laimei Longyu Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement of Resolutions of the 39th Meeting of the Fifth Board of Directors
Laimei Pharmaceutical: Pre-disclosure Notice on Passive Reduction of Some Shares Held by Shareholders Holding 5% or More
Laimei Pharmaceuticals: Notice on Obtaining Approval Notice for Drug Supplemental Applications
Laimei Pharmaceutical: Announcement on the holding subsidiary obtaining ethical approval for phase II clinical trials of nano-carbon iron suspension injections
Chongqing Lummy Pharmaceutical: Regulations on Foreign Investment Management (August 2024)
Chongqing Lummy Pharmaceutical: Announcement Regarding the Application for Credit Limit for Financial Leasing Business to Far East International Financial Leasing Co., Ltd.
Chongqing Lummy Pharmaceutical: Announcement of the first-instance judgment results of the lawsuit involving a subsidiary company under the control.
Chongqing Lummy Pharmaceutical: Board of directors resolution announcement.
No Data
No Data